RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice

Denuja Karunakaran(The University of Queensland), Katey J. Rayner(University of Ottawa), Paulina Lau(University of Ottawa), Mary‐Ellen Harper(University of Ottawa), Aldons J. Lusis(ABT Molecular Imaging (United States)), Anne‐Claire Duchez(Canadian Natural Resources), Adil Rasheed(University of Toronto), Barbara C. Vanderhyden(University of Ottawa), Hailey Wyatt(Yale University), Kirsi H. Pietiläinen(University of Helsinki), Joshua W. Kandiah(MACOM (United States)), Calvin Pan(Laboratory of Molecular Genetics), Ruth McPherson(University of Ottawa), My-Anh Nguyen(University of Ottawa), Päivi Pajukanta(University of California, Los Angeles), David Smyth(University of Ottawa), Marcus Alvarez(University of California, Los Angeles), Ludovic Boytard(NYU Langone Health), Bhama Ramkhelawon(NYU Langone Health), Michèle Geoffrion(University of Ottawa), Peter J. Gough(GlaxoSmithKline (United States)), David P. Cook(University of Ottawa), Sébastien Soubeyrand(University of Ottawa), Peter Liu(Genomic Health (United States)), Markku Laakso(Cleveland Clinic), Richard Lee(Ionis Pharmaceuticals (United States)), Scott B. Berger(GlaxoSmithKline (United States)), Majid Nikpay(University of Ottawa), Adam W. Turner(University of Virginia), John Bertin(Millennium Engineering and Integration (United States))
Nature Metabolism
September 28, 2020
Cited by 59


Related Papers